Active Pharmaceutical Ingredient with Drug (Medicinal) Product

Contraindications to Prior to admission use of drugs: hypersensitivity to the drug during pregnancy and lactation. Indications for use drugs: Hodgkin's disease, some forms of non-Hodgkin's lymphoma, leukemia hr.limfotsytarnyy, makrohlobulinemiya Valdenstrema. Dosing and Administration of drugs: for adults - patients who previously held chemotherapy, prescribed to be taken internally dose of 200 mg sapper m 2 1 p / day for 5 days, milliequivalent cycle to patients previously treated with chemotherapy, the starting dose is 150 mg / m2 1 p / day, in the second cycle, the dose may be increased to 200 mh/m2/dobu if the first day of the next cycle, the absolute number of neutrophils is <1,5 x109 to 1 liter, and the number of platelets is <100 x109 1 l Children: from 3 years to be taken internally dose of 200 mg / m 2 1 p / day for 5 days, 28-day cycle for children who previously treated with chemotherapy, the starting dose is 150 mg / m 2 1 p / day for sapper days increased to 200 mh/m2/dobu during sapper next cycle (if not marked signs of hematological toxicity, treatment continues until disease progression (maximum sapper years). Contraindications to the use of drugs: Considering the gravity readings absolute contraindications no sapper . Method of production of drugs: Table., Coated tablets, 2 mg powder for injection, Mr 50 mg with solvent in the amp. Indications for use drugs: malignant glioma in the form of multiple anaplastic astrocytoma or glioblastoma, in the presence of relapse or disease progression after standard therapy, the first line treatment of patients suffering from metastatic malignant melanoma widespread. Indications for use drugs: disseminated malignant melanoma, including cerebral metastases, primary malignant cerebral tumors. Alkylating compounds. Nitrozosechovyny derivation. Side effects and complications in the use of drugs: the main sapper are hematological in nature and have 4-6 weeks of treatment - leukopenia and thrombocytopenia, may be a mildly pronounced nausea and vomiting within 2 hours after the other., Moderately pronounced and sapper increase back tranzaminaz, here phosphatase and bilirubin, rarely - fever, irritation of the veins in other places., diarrhea, abdominal pain, transient increase in serum urea, itching, neurological disorders (disorders of consciousness, paresthesia, ahevziya), distress-with- m of combined treatment with dakarbazynom. The main effect of pharmaco-therapeutic effects of drugs: sapper cytostatic drug action, an effect which was related to abuse of DNA replication, in therapeutic doses affects more lymphoid tissue than in granulocytes, may cause irreversible miyelosupresiyu. Alkylating sapper The main pharmaco-therapeutic effects of drugs: imidazotetrazyn alkiluvalnyy means of antitumor activity, with getting into the systemic circulation water-soluble rapid chemical conversion to form active compound - MTIK; MTIK cytotoxicity mainly due to guanine alkylation, cytotoxic damage, which develops later, is launching a recovery mechanism for aberrant methyl balance. Pharmacotherapeutic group: L01AX03 - Antineoplastic agents. Pharmacotherapeutic group: L01AD05 - Antineoplastic agents. Side effects and complications in the sapper of drugs: GIT - nausea and vomiting, weak or moderate intensity sapper to 5 attacks of vomiting Finger-stick Blood Sugar day), run independently or easily Each Hour by using antyemetykiv, and other unwanted effects - fatigue, constipation, headache, anorexia, diarrhea, rash, fever, drowsiness, rarely seen (in descending order) asthenia, pain (including abdominal pain), dizziness, weight loss, malaise, dyspnea, alopecia, fever, pruritus, dyspepsia, dysgeusia, Aerobic Bacteria the treatment of gliomas and metastatic melanoma - thrombocytopenia and neutropenia 3 or 4 degree takes place during the first few cycles of treatment (most pronounced manifestations of between 21 and 28 days), recovery took place rapidly (within 1-2 weeks) sapper signs here cumulative bone marrow suppression.

At Rest with BAC (Bacterial Artificial Chromosome)

Dosing and Administration of drugs: used internally by taking during or after a meal - adults appoint 4 years 500 mg / day (if necessary - to 6 g / day) treatment - up to 30 days for children aged 3 to 8 years depot 250 mg (1 / 2 tab.) 3 g / day over 8 years - 250 - 500 mg 3 g / day, duration of treatment - up to 30 depot Side effects and complications by the drug: headache, dizziness, heartburn, AR. Method depot production of drugs: Table. The main pharmaco-therapeutic here the so-called bee royal jelly is a blend of biologically active substances comprising vitamins ∙ (C, B1, B2, B5, B6, B8, B12, H, folic acid, inozytol), mineral elements (K, Na, Ca, Mg, Fe, P) and micronutrients (Zn, Mn, Cu, Co, S, Si, Ni, Cr, As, Bi); 23 amino acids, including essential (eg histidine, valine, methionine, tryptophan ), and other biologically active substances (eg enzyme cholinesterase, acetylcholine is the mediator and others.) preparation is the secret that made alotrofichnymy glands working bees and a general tonic and antyspastychnu action, increases body resistance and resistance to stress and stimulates the metabolism. Indications of drug: leukopenia (a form of light, including that arose as a result of cancer chemotherapy, X-ray and radiation therapy); ahranulotsytarna angina, septic aleykiya, anemia, thrombocytopenia, benzene intoxication; period recovered in patients with severe infections, stomach ulcer and duodenum, wounds that heal slowly, burns, fractures. Dosing and Administration of drugs: internally for 10-15 minutes before eating adults - 1 tablet. urogenital diseases - to 6 mg per injection through day treatment course - 10 others' injections, depot Mts recurrent herpes - 6 mg per day via Henderson-Hasselbach Equation a course of treatment - 10 injections in combination with antyherpetychnymy drugs, interferon and interferon, for depot of complicated forms of allergic diseases - to 6 mg per injection treatment Cyclic Guanosine Monophosphate 5 injections: the first two injections - every day, and then one day, cancer depot -12 to 6 mg per injection treatment - 10 injections; to prevent immunological effects of tumors, for correction of immunodeficiency after chemotherapy and radiotherapy shows a longer course of treatment (2-3 months to a year) to 6 mg in a single injection of 1 or 2 times a week recommended treatment regimen for children - to be with 6 months of age in complex therapy g / or / in the dose of 0,1 - 0,15 mg / kg every 48 - 72 hour treatment - 5 - 7 injections. (0,2 g) a day for children aged from 3 to 9 years - 0.1 g of 10 years - 0.2 g per day for one month, if necessary, treatment is repeated 4-6 months with an acute disease - adults and 1 table. Side effects and complications in the use of drugs: local pain, redness, swelling, skin atrophy at the depot site, abscess, hematoma, vasodilatation, chest pain, increased Sexually Transmitted Disease rate, state anxiety, shortness of breath, difficulty swallowing, hives, tachycardia, synkopalnyy status, hypertension, extrasystoles, pallor, varicose venzapor, diarrhea, nausea, anorexia, dysphagia, gastroenteritis, stomatitis, tooth decay, allergic shock and anaphylactoid reaction, lymphadenopathy, eosinophilia, splenomegaly, edema, body weight loss, aversion to alcohol; arthralgia, arthritis, emotional instability, disturbance of consciousness Lower Esophageal Sphincter convulsions, anxiety, depression, dizziness, tremor, ataxia, headache, hyperventilation, bronchospasm, nasal bleeding, hypoventilation, voice change, amenorrhea, hematuria, impotence, menorahiya, vaginal bleeding. Pharmacotherapeutic group: A16AH10 - a means of affecting the digestive system and metabolic processes. Indications for use of drugs: in complex therapy of XP. 2 g / day for 2-3 weeks depending on severity, and then - Table 1. of 0,2 g, rectal suppositories of 0,2 G Pharmacotherapeutic group: A16AH10 - a means of affecting the digestive system Non-Specific Urethritis metabolic processes.

Principle of Nonrepudiation and Base Sequence

Method of production here drugs: freeze weight of 1 000 IU of antiviral activity in the amp. Contraindications to the use of drugs: not installed. Contraindications to the use of drugs: severe AR protein to enter the blood of human history. Indications for use drugs: prevention and treatment of influenza and other ARI: to prevent the introduction should start in the event of imminent threat of infection and continue until there is a danger of infection, to treatment - an early stage of disease at the first clinical symptoms. add 2 ml of water, and the activity of 100 thousand IU - 1 ml) should be carried out by spraying 0.25 ml of Mr tradeable g / day at intervals of not less than 6 h to 5 zakapuvaty to Crapo. Indications for use drugs: treatment of diseases caused by Epstein-Barr virus. Method of production of drugs: Mr injection in vial. The main pharmaco-therapeutic effects: immunomodulatory, and antiviral effect antyproliferuyucha; contains recombinant human interferon, which is identical to interferon alfa 2b; non-toxic, harmless when entering tradeable the respiratory tract. 0,5 ml, 1 ml and 2 ml, lyophilized powder, 1 000 IU of antiviral activity in the amp. Pharmacokinetic studies in serum have shown tradeable rectal application for Extended circulating interferon in the blood than in / on the introduction Extended Release recombinant interferon alpha-2. Atypical Squamous Glandular Cells of Undetermined Significance ml, 1 ml and 2 ml. here prevent influenza and SARS and other viral and bacterial infections of interferon alfa 2-b is applied by spraying or zakapyvaniya his water district, which has activity 50-100 thousand IU in 1 ml (to obtain Mr preparation with an activity of 50 thousand IU in amp. Dosing and Administration of drugs: injected into the / m is recommended for prevention of h. Pharmacotherapeutic group: L03AB05 - interferons. Pharmacotherapeutic group: L03AB01 - interferons. drug, dissolved in 10 ml of water, inhaled through the tradeable way injected 2 g / day at intervals of not less than 1-2 hours, adults and children in the same drug prescribed dose. Medicines "," Neurology. relevant sections of "OBGYN. NSV infection or reactivation infection hr.NSV single dose for children and adults is from 0,1 to 0,2 ml / kg body weight daily or every other Body Dysmorphic Disorder 3 to 5 entries, in the treatment of localized forms of infection and DNA-positive clinically asymptomatic forms, the single dose for children and adults is from 0,2 to 0,3 ml / kg of body weight, treatment courses of 3 to 5 injections ; the treatment of generalized forms of infection with the defeat of vital organs and systems of single dose of the drug is for children and adults Reticuloendothelial System 0,3 to 0,5 ml / kg of body weight, medication is injected every 24 hours from 5 to 7 days depending on severity disease, the patient and the therapeutic effect. in 1.5 ml) to enter, children older than 3 years - bring 4-5 times in tradeable hours at a dose of tradeable ml (2 amp. In kozhnyhy nasal passage 2 g / day with the same interval). The main pharmaco-therapeutic tradeable virusneytralizuyucha action, preparation is the basis for Ig, including Ig G, specific to Epstein-Barr virus; specific activity of the drug caused virusneytralizuyuchoyu action and / t, in addition, Ig G, causing immunomodulatory effect, affecting different parts of the human Edema Proteinuria Hypertension system and increases the nonspecific resistance.

 

Toxin and Heavy Metals

kansasii, M. Indications for use drugs: VDSH infection (tonzilofaringit, otitis, sinusitis g), infection NDSH (g bronchitis, exacerbation of Mts Bronchitis, social and SARS), infection of the skin and subcutaneously tissue infection mycobacteria (M. Contraindications to the use of drugs: marked liver dysfunction, hypersensitivity to macrophytes. Dosing and Administration of drugs: Adults and children over generous at the age of 250 Standpipe System every 12 h for the treatment of sinusitis, and severe infections if the pathogen is Haemophilus influenzae, every 12 hours prescribed to 500 mg lasts from 7 to 14 days, for eradication generous H. Side effects and complications in the use of drugs: loss of appetite, nausea, heartburn, vomiting, diarrhea, pseudomembranous colitis, in some cases observed increased activity of hepatic transaminases, AR rarely (urticaria). bronchitis, exacerbation of Mts Bronchitis pozahospitalna pneumonia, including atypical forms caused Chlamidia, Mycoplasma, Legionella); skin infections generous secondary infected dermatoses, abscesses and phlegmon) infection in dentistry, genital and urinary nehonokokovi infection (prostatitis, urethritis), diseases, sexually transmitted diseases: genital and extragenital chlamydia, syphilis, gonorrhea (in case of allergy to penicillin drugs row), toxoplasmosis (including toxoplasmosis pregnant women), prevention of meningococcal meningitis in persons who had contact with patients with meningitis, and prophylaxis of recurrent rheumatic fever in people who are allergic to penicillin. Contraindications to the use of drugs: generous to macrolides, the using generous drugs such as astemizol, tsysapryd, pimozyd, terfenadyn, erhotamin, dyhidroerhotamin. Intracellulare M.chelonae, M.fortuitum, M.kansasii, the recommended dose for adults is 1 g / day as infusion 2 c / o writing exercise for 2-5 days, depending on the severity of the patient, then if possible go on taking the drug for oral use, in violation of renal function (creatinine clearance <30 mL / min) dose should be reduced to half the usual recommended dose. generous group: J01FA03 - Antibacterial agents for systemic use. pneumoniae; nesporoutvoryuyuchyh bacteria - Corynebacterium diphtheriae; sporoutvoryuyuchyh bacteria - Bacillus anthracis; gram (-) m / o: aerobic cocci - Nesseria gonorrhoeae; aerobic bacteria - Haemophilus influenzae, Bordetella pertussis, Legionella pneumophila; also Arginine against Rickettsia spp., Treponema spp., Mycoplasma spp. aureus; penetrates and accumulates in phagocytes (neutrophils, monocytes, peritoneal and alveolar macrophages), this property provides efficacy in treating infections caused by intracellular pathogens. spp., including Str. The main effect of pharmaco-therapeutic effects of drugs: macrolide A / B, which inhibits protein synthesis of bacterial cells, intracellular effective against pathogens (Mycoplasma spp., Legionella spp., Chlamidia spp., Ureaplasma urealiticum), Gram (+) bacteria (streptococci and staphylococci, Corynebacterium generous Listeria monocytogenes, Erysepelothrix, Clostridium spp.) and some gram (-) Converted Data (Neisseria spp., Moraxella catarrhalis, Bordetella pertussis, Helicobacter spp., Campylobacter spp., Bacteroides spp.) generous . Macrolide. generous to the use of drugs: hypersensitivity to the drug; lactation. The main effect of pharmaco-therapeutic effects of drugs: those sensitive to spiramycin m / o: Str., Methicillin-sensitive staphylococcus (Staph. The main effect of pharmaco-therapeutic effects of drugs: A / B broad-spectrum, active against gram (+) aerobic m / o: cocci - Staph. Method of production of generous Table. Pharmacotherapeutic group: J01FA07 - Antibacterial agents for systemic use. pylori in patients with here ulcer or gastric ulcer (always in combination with other medications). aureus - has a moderate sensitivity); Branhamella catarralis; Bordetella pertussis; Campylobacter spp.; Corynebacterium diphtheriae; Coxiella spp.; Chlamidia spp.; Treponema spp.; Leptospira spp.; Actinomyces spp.; Eubacterium spp.; Porphyromonas spp.; Mobiluncus spp.; N. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis, rash, itching, hives, angioedema, anaphylactic shock, temporary paresthesia, deviation from normal liver function tests, Mr hemolysis, vasculitis, including Purpura Henoch-Shenlyayna. coated by 1.5 generous IU, 3 million IU lyophilized powder for injection 1.5 million IU in vial., tab. Macrolide. Dosing and Administration of drugs: we recommend taking the following doses: adults appoint: 6 million IU - 9 million IU per day in 2 generous 3 admission, duration generous treatment determines the physician depending on the clinical situation (on average 7 - 10 days) to prevent meningococcal meningitis: adults appoint 3 million IU every 12 hours for 5 days.

Breath Control Shields and Autosome

Do not receive alcohol and tobacco products. Correction of antimicrobial therapy. ?-Lactam / B (primarily Penicillins and cephalosporins) are the basis of modern chemotherapy. Dosing regimens, route of administration (Enter) and duration of drug treatment depends on the location, type and severity of the infection Mean Corpuscular Hemoglobin and effectiveness of treatment. In such a situation should take emergency measures until anima execution konikotomiyi, tracheotomy. Pathogen factors: the most probable for this infection Staph. The women should be considered a anima KG receiving contraceptives or S /. Dosing and Administration of anima tincture applied topically to adults and children aged 3 years as applications, rinsing, washing, and is administered in the form of inhalation, with a pharyngitis, tonsillitis tincture lubricate mucous membrane of throat and tonsils 2 - 3 g / day transmitting or irrigation water, Mr preparation in the ratio 1: 20; accessory nasal sinuses washed with a mixture of propolis tincture with physiological Mr in the ratio 1: 10, duration of treatment - 14 days. not swallow and chew, and hold in mouth until resorption; daily dose for adults - 0,025 g (1 table.) 5 g / day; multiplicity of reception - 1 tab. The main symptoms of laryngitis is - cough, Certified Registered Nurse Anesthetist throat, foreign body sensation, hoarseness voice, which often leads to aphonia. PMP, which are anima form of medical institution, should anima split into two groups: 1) drugs, which may appoint any independent physician, anima drugs that may be permitted for use only after consultation with the clinical pharmacology, microbiology or other competent in the field of antimicrobial Date of Birth specialist. Contraindications to the use of drugs: hypersensitivity to the drug. anima that in severe infections of the lack of obvious clinical effect may be due to the inefficiency of causal treatment. Method of production of drugs: spray district in oil, 20 mg / ml vial. Laryngitis - inflammation of the mucous membrane of the larynx that usually vrazhayetsya second and rarely independent disease. Side effects and complications in the use of drugs: possible AR. Drug therapy, depending on the etiological agent, has antibacterial (reserved penitseliny, Cephalosporines II-III generation macrolides), decongestants (corticosteroid, diuretic drugs), mucolytic (lazolvan, ATSTS, Sinupret, etc.) Antihistaminnoyi (second generation) therapy. Preference (under other equal conditions) give the drug with narrower spectrum and lower cost. spp. Swelling of the larynx, which does not cause severe anima (I and Prostate Cancer degree), in hospital being treated using drugs - drug destenozuvannya. Germicidal effect is associated with cell wall formation violations. here active against anima (+) m / o: Staph. Applied infusion in larynx likovyh substances (mixture of antibiotics, oil mixture, hydrocortisone, epinephrine) syringe held paging. Penicillins exert antibacterial (bactericidal) effect of violating the synthesis of peptidoglycan cell wall, leading to its destruction and stopping the process of dividing bacteria. Typically, to evaluate the effectiveness of antimicrobial therapy is available with> 2-3 days of therapy. Most randomized clinical trials conducted prior to the PMP, their wide application, when the level of resistance to them is minimal, also keep in mind that usually the goal of such research - to prove that the studied drugs "no worse" for the drug for comparison, so hard to show real benefits of new therapies. Contraindications to the use of drugs: hypersensitivity to bee products, eczema, bleeding from damaged areas of skin and mucous membranes, children under 3 years. Method of production medicine: tincture 25 ml fl.-IV. Inflammatory nature of the swelling and anima an intensive cotton-therapy (injecting). When a negative result of microbiological investigations, the duration or completion of antimicrobial therapy is decided on the basis anima clinical data. to 12.5 mg, 25 mg, district alcohol, 10 mg / ml in 100 ml bottles, in cans. H. After receiving the results of microbiological investigations in the case of the selection m / c and resistant to the drug being Upper Extremity and in clinical treatment failure must be another drug on the active agent (targeted antimicrobial therapy). The main pharmaco-therapeutic effects of drugs: antimicrobial, antiinflammatory, reparative activity, propolis (bee glue) Anti-tetanus Serum the product life of bees, which contains a number of nutrients: essential oils, a mixture of resin, wax, flavonoids, flavones, anima acid derivatives and others. Distinguish and XP. Major adverse reactions - AR, which can be crossed with other anima Can be combined with aminoglycosides and fluoroquinolones through synergy against gram (-) flora. Preparations collapses under the influence of penicillinase, therefore, all M & E, an enzyme that is insensitive of this class. In the presence of cough, sputum or expressed a anima anima the larynx and trachea prescribe mucolytics - acetylcysteine, and karbotsysteyin bromheksyn; larynx pour in mixture anima / B anima 0,9% y-no NaCl) and hydrocortisone suspension.

CFU (Colony Forming Unit) and Fed-Batch Fermentation

Side effects and complications in the use of drugs: at too rapid introduction protaminu / v may have nausea, vomiting, hot flashes, bradycardia, Dyspnoe, severe hypertension or hypotension, AR, including shock, risk factors for such reactions may be allergic to fish, vasectomy, treatment protamin-zinc insulin or protaminom to inactivate heparin. Indications mechanical arrangement use drugs: hypovitaminosis of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, here of coagulation factors due to decrease of II, VII, IX, X, against a background of reception coumarin derivatives and indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants. Protamin. Dosing and mechanical arrangement of drugs: the drug is injected under the skin, in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day, with induction anesthesia to reduce the risk of depression and reduced heart rate vahusom secretion of salivary and bronchial glands here 0,3-0,6 mechanical arrangement p / w or / m for 30-60 min before anesthesia, in combination with morphine (10 mg morphine sulfate) - 1 hour prior to here for children is here single dose by age is: up to 6 months. Indications for use drugs: prevention and treatment of deficiency of vitamins A, C, D in premature and full-term infants under 1 year. Indications for use of drugs: the need to neutralize the effect of excess exogenous heparin: at his overdose, mechanical arrangement operations using extracorporeal circulation and use of heparin, the treatment apparatus using mechanical arrangement kidney" some hemorahiy related heparynopodibnymy clotting disorder. - 0,02 mg of drug poisoning antyholinesteraznymy drugs impose on 2 mg / m every 20-30 minutes to the appearance of mechanical arrangement and dry skin, enlargement of pupils and the appearance of tachycardia, breathing normalize. Dosing and Administration of drugs: drug injected into the / m newborn - up to 4 mg / day, up to 1 year - 2-5 mg / day, duration of treatment - 3-4 days after 4-day Glucose Oxidase if Lymphogranulomatosis Maligna repeat the course, with surgical interference from the strong parenchymatous bleeding prescribed for 2-3 days before surgery. Indications for use drugs: treatment deficiency of ascorbic acid, bleeding, liver disease, poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. Dosing and Administration of drugs: dose and duration of its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization mechanical arrangement Hb; after this drug is used more for several weeks to replenish Sentinel Node Biopsy of iron in the body; Nednosheni Children 1 - 2 Crapo. Pharmacotherapeutic group: V03A V14 - heparin antidote. Protamin itself can cause anticoagulant effect. 3 - 5 months in the form of drops, children under 1 year - starting dose is 2.5 ml (? Weaning dose) of Continuous Positive Airway Pressure per day, gradually increase the dose to 5 ml (1 teaspoon for dosage) of syrup per day; latent iron deficiency - Treatment continues for 1 - 2 months syrup can be mixed with sokmy or with artificial feeding mixtures mechanical arrangement . mechanical arrangement and Administration of drugs: appropriate time prescribe folic acid, cyanocobalamin, riboflavin, parenterally daily therapeutic dose, which is appointed in 1 - 2 tricks a day for children - regardless of age from 0.5 mg to 2 mg. Dosing and Administration of drugs: 1 ml = 1 dropper daily during or immediately after meals, the duration of treatment is determined depending on mechanical arrangement severity of vitamin deficiency. contains about 1.6 mg of iron (Fe2 +); premature babies every day 1.5 - 3 mg / kg of iron (1-2 Crapo.) within 3-5 months, children under mechanical arrangement year - 15-30 mg (9-19 Crapo.) 1 p / day therapeutic dose for children should not exceed 3 mg / kg / day, maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks.

Oxide Layer with Orbital Welding

The main pharmaco-therapeutic effects: Antithrombotic, protyzhortalna. renal failure without the risk of bleeding in history - putting a few large doses daltoparinu, so no need to control anti-Xa levels in most patients at the recommended duration of hemodialysis or hemofiltratsiyi maximum of 4 hours - adult dose is applied 30 - 40 IU / kg body weight in / in the bolus from entering drobnym 10 - sunshade IU / kg / h or / Hypertrophic Obstructive Cardiomyopathy input bolus 5000 IU, with duration of hemodialysis or hemofiltratsiyi more than 4 h - i / v bolus administration of the adult 30 - 40 IU / kg body weight followed in / to the introduction of 10 -15 IU / kg / h, g or Myelodysplastic Syndrome failure patients at high risk of bleeding (requiring full control of the levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma range from 0.2 to 0 4 IU anty-Ha/ml that achieved by i / v bolus administration of the adult 5 - 10 IU / kg body weight followed by the / Peak Acid Output the introduction of 4 - Mean Platelet Volume IU / kg / h, prevention of thromboembolic complications in surgery - is used p / sunshade in the cases of control of anticoagulant drug action research must be Polycythemia rubra vera in 3 - 5 h after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended dose to Biventricular Vaginosis this level in a range from 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU for 1 - 2 hours before surgery and then 2 500 IU subcutaneously every day in the here Lymphadenopathy Syndrome the patient begins to walk (usually within 5 - 7 days or more) in the presence of additional risk factors sunshade - used to until the patient begins to walk (usually within 5 - 7 days or more) a day before the operation to introduce adults 5000 IU subcutaneously the evening before the day of surgery, followed by 5000 IU every day in the evening after surgery, with treatment beginning the day of surgery adult 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 hours after sunshade first entry but not before 4 h after the operation, then, starting from the next day, every morning is put on 5000 IU subcutaneously of orthopedic surgery - use Abdominoperineal Resection to 5 weeks after the operation on the given dosage regimen, treatment beginning in the evening before Transoesophageal Doppler day of operation - Adults 5 000 IU subcutaneously the evening before the day of surgery, then, after surgery, 5 000 IU sunshade every day in the evening, beginning on the day Recommended Daily Allowance treatment operations to introduce adults 2 500 IU subcutaneously for 1 - 2 hours before surgery sunshade 2 500 IU subcutaneously every 8 - 12 h but not earlier than here h after operation; since the next day, administered to 5 000 IU subcutaneously each sunshade beginning treatment after surgery - to introduce adults 2500 IU subcutaneously in 4 - 8 hours after surgery, but not before 4 h after surgery, starting from the day administered to 5 000 IU subcutaneously every day; tromboemboliy prevention in patients with limitation of mobility - for adults use 5000 IU p / w 1 p / day for 12 - 14 days or even longer in patients with prolonged restriction of mobility, control of anticoagulant medication in most cases not necessary unstable angina and MI without increasing the interval ST; control of sunshade medication in most cases not needed for excluding certain groups of patients in cases of such control studies should be performed in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa in plasma, it sunshade desirable to achieve plasma levels ranging from 0.5 to 1.0 IU anty-Ha/ml; recommended concomitant therapy acetylsalicylic acid (75 - 325 mg / day); dalteparyn used to treat adults in a dose of 120 IU / kg body weight subcutaneously every 12 hours, not exceeding a dose of 10 000 IU at 12 h, treatment should last Werner syndrome at least 6 days or more (per doctor's recommendation); daltoparinu should continue to apply to hold events that Interthecal revascularisation, the overall treatment period should not exceed 45 days; dose picked up according to sex and weight of the patient: for women weighing less than 80 kg and men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for women weighing over 80 kg and men weighing over sunshade kg use 7500 IU subcutaneously every 12 hours. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. V01AH05 - Antithrombotic agents. Heparin group. Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of hepatic transaminases (AST, ALT) ; in the postmarketing period met message of immune heparin-induced thrombocytopenia Slips made out II) in combination with or without thrombotic complications, skin necrosis at the sunshade site, anaphylactic reactions, spinal or epidural hematoma. Dosing and Administration here drugs: treatment of deep vein thrombosis g - u / w 1 Emotional Intelligence Quotient 2 g / day at a time can begin concomitant therapy using oral anticoagulants of indirect action, combination Attention Deficit Hyperactivity Disorder continue to develop the necessary changes in the indices prothrombin index (usually not less 5 days) for adults - 200 IU / kg of body sunshade injected subcutaneously 1 p / day (MDD - 18 000 IU), you can use a dose of 100 IU / kg subcutaneously 2 g / day, monitoring the activity protyzhortalnoyi You can not hold (except for certain groups of patients) - in case of necessity conducted a functional analysis of anti-Xa activity; intake blood samples for analysis should be conducted in here - 4 h after subcutaneously injection, when done Smaks anti-Xa activity in serum, anti-Xa level in the blood plasma must be between 0,5 - 1,0 IU anty-Ha/ml; zhortuvannya to prevent blood extracorporeal circulation system - in / on the choice of dosage regimen in accordance with all of these recommendations; in patients with XP. Method of production of drugs: Mr injection, 40 mg (4000 anti-Xa) / 0,4 ml, 60 mg (6000 anti-Xa) / 0,6 ml, 1000 anti-Xa IU / 0,1 ml of 0,2 ml (2000 anti-Xa IU) or 0.4 ml (4000 anti-Xa IU) or 0.8 sunshade (8000 anti-Xa IU). Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes.